Sineva Pharmaceutical was established in May 2017 with a registered capital of 200 million yuan, owning over 40 patents, and achieving a sales revenue of 200 million yuan in 2022;Located in the largest western medicine distribution center in China, in the economic development zone of Taihe County, Fuyang City, a provincial chemical concentration area.Engage in R&D, production and sales of pharmaceutical intermediates and APIs, providing professional CMO/CDMO services;Sineva Pharmaceutical has one pilot plant and two multifunction production workshops with multiple standardized production lines, capable of meeting different process conditions for low-temperature, ultra low-temperature, hightemperature, low-pressure, medium- pressure and high- pressure production demands.